No Data
No Data
Weight-loss version of semaglutide launched in the Chinese market! novo-nordisk a/s (NVO.US) unlocks new growth engine.
novo-nordisk a/s launched Wegovy in china, with prices lower than in the usa; this is an important step for the company to intensify its investment in the rapidly growing market in china.
Top Gap Ups and Downs on Monday: TSLA, SMCI, LYFT and More
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Top Midday Stories: Spirit Airlines Files for Chapter 11 Bankruptcy Protection; Trump Team Looking to Ease Rules for Self-Driving Cars
European Equities Traded in the US as American Depositary Rise in Monday Trading
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
No Data
No Data